Assignee
LINNAEUS THERAPEUTICS INC
US·2 granted patents·6 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
8 records- 0178US2023382896A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0278US2025171421A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0370US10934277B2Enantiomerically purified GPER agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2019·Granted Mar 2, 2021·0 cites·11 claims
- 0466US11760749B2Enantiomerically purified GPER agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·0 cites·11 claims
- 0566US2022089576A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0661US2020024262A1Enantiomerically purified gper angonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0754US2024376547A1Oncologic variations associated with cancer and methods of treatmentLINNAEUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0852US2024245674A1Diagnostic methods and compositions for treatment of cancerLINNAEUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LINNAEUS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →